Overview

Central China Rosai-Dorfman Disease Registry

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a research study among patients with Rosai-Dorfman disease.
Phase:
Phase 4
Details
Lead Sponsor:
Tongji Hospital
Treatments:
Mycophenolic Acid
Prednisone